rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Stephen H. Rusckowski

Director

Company insider

Files Form 4 as: Director, Oracle; Director, Tenet Healthcare; Director, Baxter International; Chairman, CEO and President, Quest Diagnostics; Director, Xerox; Director, Covidien.

In numbers

Trades disclosed
174
Buys
3
Sells
17
Bought
$4.9M
Sold
$203.2M
Companies
6
Companies where not an officer
5
First trade
1 May 2012
Last trade
29 Sep 2026
Last filed
1 Oct 2026

Companies traded

Where they are an officer
DGX Quest DiagnosticsDirector, Officer · Diagnostics & Labs · last 6 Mar 20232 buys · 17 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ORCL OracleDirector · Software · last 29 Sep 20261 buy · 0 sells
THC Tenet HealthcareDirector · Providers & Facilities · last 23 May 20250 buys · 0 sells
BAX Baxter InternationalDirector · Medical Devices · last 6 May 20250 buys · 0 sells
XeroxDirector · last 12 Jan 20180 buys · 0 sells
CovidienDirector · last 26 Jan 20150 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
29 Sep 2026filed 1 Oct 2026ORCL OracleSoftwareSEC FORM 4 Bought$3.5M25,000 at $139.35filing
31 May 2026filed 2 Jun 2026ORCL Oracleoption or derivative · SoftwareSEC FORM 4 Code A—1,550 at $0.00filing
31 May 2026filed 2 Jun 2026ORCL Oracleoption or derivative · SoftwareSEC FORM 4 Code A—1,550 at $0.00filing
18 Nov 2025filed 20 Nov 2025ORCL Oracleoption or derivative · SoftwareSEC FORM 4 Code A—793 at $0.00filing
23 May 2025filed 27 May 2025THC Tenet Healthcareoption or derivative · Providers & FacilitiesSEC FORM 4 Code M—1,551filing
23 May 2025filed 27 May 2025THC Tenet HealthcareProviders & FacilitiesSEC FORM 4 Code M—1,551filing
22 May 2025filed 27 May 2025THC Tenet Healthcareoption or derivative · Providers & FacilitiesSEC FORM 4 Code A—1,333 at $0.00filing
6 May 2025filed 8 May 2025BAX Baxter InternationalMedical DevicesSEC FORM 4 Code A—7,183 at $0.00filing
23 May 2024filed 28 May 2024THC Tenet Healthcareoption or derivative · Providers & FacilitiesSEC FORM 4 Code A—1,551 at $0.00filing
7 May 2024filed 9 May 2024BAX Baxter InternationalMedical DevicesSEC FORM 4 Code A—5,952 at $0.00filing
21 Aug 2023filed 23 Aug 2023BAX Baxter InternationalMedical DevicesSEC FORM 4 Code A—3,049 at $0.00filing
26 May 2023filed 23 Jun 2023THC Tenet HealthcareProviders & FacilitiesSEC FORM 4 Code A—3,682 at $0.00filing
26 May 2023filed 30 May 2023THC Tenet HealthcareProviders & FacilitiesSEC FORM 4 Code A—2,846 at $0.00filing
6 Mar 2023filed 8 Mar 2023DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Code A$12.2M82,631 at $147.86filing
6 Mar 2023filed 8 Mar 2023DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Code F$5.7M38,604 at $147.86filing
1 Mar 2023filed 3 Mar 2023DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Code F$492K3,496 at $140.69filing
23 Feb 2023filed 27 Feb 2023DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Code F$861K5,826 at $147.86filing
23 Feb 2023filed 27 Feb 2023DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Code A—20,059 at $0.00filing
25 May 2022filed 26 May 2022DGX Quest Diagnosticsoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$1.0M10,037 at $103.57filing
25 May 2022filed 26 May 2022DGX Quest Diagnosticsoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$1.3M14,854 at $86.63filing

Sectors

Health Care19
Technology1

Buys in green, sells in red, by the company’s sector.

Related people

Timothy C. WentworthDirector · Director at Quest Diagnostics, filing Form 4 there in the last year
J. E. DavisCEO and President · CEO and President at Quest Diagnostics, filing Form 4 there in the last year
Michael E. PrevoznikSVP & General Counsel · SVP & General Counsel at Quest Diagnostics, filing Form 4 there in the last year
Mark E. DelaneySVP & Chief Commercial Officer · SVP & Chief Commercial Officer at Quest Diagnostics, filing Form 4 there in the last year
Robert B. CarterDirector · Director at Quest Diagnostics, filing Form 4 there in the last year
Donald J. TrumpPresident · Also traded ORCL and DGX in the last 90 days
Maria SmithEVP, Chief Accounting Officer · Also traded ORCL in the last 90 days
Michael D. SiciliaChief Executive Officer · Also traded ORCL in the last 90 days